Cirrhosis: Clinical sciences

Last updated: January 30, 2025

Cirrhosis: Clinical sciences

Gastrointestinal

Gastrointestinal

Esophagitis: Clinical sciences
Esophageal disorders: Pathology review
Esophageal cancer: Clinical sciences
Esophageal cancer
Esophageal perforation: Clinical sciences
Esophageal cancer: Year of the Zebra
Eosinophilic esophagitis (NORD)
Esophageal disorders: Clinical
Gastroesophageal reflux disease: Clinical sciences
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Approach to melena and hematemesis: Clinical sciences
Esophagitis: Clinical
Achalasia: Year of the Zebra
Gastroesophageal reflux disease (GERD)
Esophageal web
Barrett esophagus
Diffuse esophageal spasm
Portal hypertension
Mallory-Weiss syndrome: Clinical sciences
Gastrointestinal bleeding: Pathology review
Gastroesophageal varices: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease (GERD): Clinical
Gastric cancer: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pancreatic cancer
Pancreatitis: Pathology review
Chronic pancreatitis
Acute pancreatitis
Pancreatic neuroendocrine neoplasms
Chronic pancreatitis: Clinical sciences
Pancreatic cancer: Clinical sciences
Acute pancreatitis: Clinical sciences
Zollinger-Ellison syndrome
Multiple endocrine neoplasia: Clinical sciences
Cystic fibrosis
Stress ulcers: Clinical sciences
Ulcerative colitis
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease: Pathology review
Gallbladder carcinoma
Gallbladder disorders: Pathology review
Acute cholecystitis
Gallstones
Gallstone ileus
Cholecystitis: Clinical sciences
Biliary colic
Chronic cholecystitis
Approach to upper abdominal pain: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Ascending cholangitis
Cholestatic liver disease
Jaundice: Pathology review
Jaundice
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Jaundice: Clinical
Neonatal jaundice: Clinical
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Hepatitis C: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis A and E: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Hepatic encephalopathy
Viral hepatitis: Clinical
Hepatocellular carcinoma
Cirrhosis: Pathology review
Colorectal cancer
Ischemic colitis: Clinical sciences
Colorectal polyps
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical sciences
Approach to constipation: Clinical sciences
Approach to hematochezia: Clinical sciences
Diverticulitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Fecal impaction: Clinical sciences
Diverticular disease: Pathology review
Small bowel obstruction: Clinical sciences
Clostridium difficile (Pseudomembranous colitis)
Inflammatory bowel disease (Crohn disease): Clinical sciences
Diverticulosis and diverticulitis
Ileus: Clinical sciences
Familial adenomatous polyposis

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

Start
A 58-year-old man presents to the office to follow up on recent blood testing. The patient has no previously diagnosed medical conditions. The patient has been feeling more fatigued recently but attributes it to working long hours. The patient drinks 6-8 cans of beer on weekday evenings and 10-12 cans on weekend days. Temperature is 37.0 ºC (98.6° F), pulse is 84/min, and blood pressure is 132/74 mmHg. Physical exam shows palmar erythema and spider angiomas. Neurologic examination is normal. There is no distension of the abdomen and no abdominal tenderness to palpation. Lab results are shown below. Ultrasound of the abdomen shows a small, nodular liver and minimal ascites. The patient is referred for upper endoscopy which shows medium varices with no signs of active bleeding. Which of the following medications should be started at this time?  

Laboratory value
Result   
Reference range
Blood count  


Hemoglobin
11.0 g/dL
13.5-17.5 g/dL
Platelets
108,000/mm3   
150,000-400,000/mm3   
Metabolic Panel  


BUN
10 mg/dL
7-18 mg/dL
Creatinine
1.5 mg/dL  
0.6-1.2 mg/dL  
AST
118 U/L  
8-40 U/L  
ALT
55 U/L  
8-40 U/L  
Alkaline phosphatase  
165 U/L  
20-70 U/L  
Gamma-glutamyl transpeptidase  
140 U/L  
5-40 U/L  
Total bilirubin  
2.3 mg/dL  
0.1-1 mg/dL  
Albumin
2.8 g/dL  
3.5-5.5 g/dL  
INR
1.4  
≤1.1  

Transcript

Watch video only

Cirrhosis refers to chronic progressive fibrotic changes of the liver parenchyma that occur in response to chronic injury and inflammation. A variety of conditions can cause this injury, including viral hepatitis, chronic alcohol use, autoimmune disease, and hereditary conditions like hemochromatosis or alpha-1 antitrypsin deficiency, and the ensuing fibrotic changes eventually impair liver function.

Early in the disease process, cirrhotic patients remain relatively asymptomatic and are considered to have compensated cirrhosis, while those who present with symptoms are considered to have decompensated cirrhosis. Complications due to cirrhosis include spontaneous bacterial peritonitis, ascites, variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome, which can be life-threatening, therefore it’s important to quickly identify these patients who may suddenly decompensate.

Now, if you suspect cirrhosis, first perform an ABCDE assessment to determine if your patient is unstable. Keep in mind that cirrhosis is never unstable unless it's decompensated and the patient develops complications. If this is the case, you may need to secure the airway, breathing, and circulation, which might require intubating the patient, and starting mechanical ventilation. Next, obtain IV access and, if your patient is hypotensive, start IV fluids for volume resuscitation. If there are signs of blood loss, they might even need a transfusion of blood products, such as packed red blood cells, platelets, and even fresh frozen plasma. You should also continuously monitor vital signs.

Additionally, if you suspect decompensated cirrhosis complications, it’s important to identify the underlying cause and complication. To do so, start by performing a focused history and physical examination, and depending on the suspected complication, you may want to order labs or ultrasound.

Alright, if your patient presents with abdominal distension and a palpable fluid wave, and ultrasound reveals free fluid in the peritoneal cavity, that’s ascites. On the other hand, if your patient has fever and abdominal pain, and labs reveal a positive ascitic fluid culture with PMN predominance, your patient has spontaneous bacterial peritonitis. If you notice signs of blood loss, such as melena, hematochezia, and hematemesis, with anemia on labs, think of variceal bleeding.

If instead your patient presents with neurologic signs, such as altered mental status and flapping tremor, also known as asterixis, that’s hepatic encephalopathy. Lastly, if your patient has dark urine and oliguria, and their labs show elevated creatinine, but there’s no evidence of an intrinsic kidney disease, you should think of hepatorenal syndrome, keeping in mind that it’s a diagnosis of exclusion. Once you’ve identified your patient’s specific complication, the management includes treatment of the underlying cause and complication, including consulting the appropriate specialists and the surgical team. For definitive treatment, consider liver transplantation.

Now, here’s a clinical pearl to keep in mind! Active variceal bleeding in a cirrhotic patient carries a high mortality rate and can be challenging to manage. Not only is the presence of variceal bleeding associated with advanced disease in the first place, but variceal bleeding, by its very nature, is under increased pressure from portal hypertension. Further, cirrhotic patients typically have coagulopathy and thrombocytopenia, so their ability to clot is impaired, and gaining control of the bleeding is not easy. Hypotension and hemorrhagic shock may ensue, and volume resuscitation is challenging since albumin is already low. So, you should use colloids, albumin, and blood products to achieve hemodynamic stability. Finally, immediately call the endoscopy team to stop the bleeding.

Ok so let’s go back to the ABCDE assessment where your patient is instead stable and cover compensated cirrhosis. First, obtain a focused history and physical examination, as well as labs, including CBC, CMP, PT, PTT, and possibly ammonia level. In compensated cirrhosis, the remaining healthy liver parenchyma is still able to compensate for systemic demands of liver function. As a result, these patients are usually asymptomatic, and they haven’t developed overt complications from cirrhosis; some may present with varices, but they haven’t had any episodes of variceal bleeding.

Now, since these patients are asymptomatic, they may come to clinical attention on routine lab evaluation. Lab findings might include elevated hepatic transaminases AST and ALT, alkaline phosphatase or ALP, bilirubin, clotting studies like PT and PTT, and ammonia levels; as well as decreased albumin and thrombocytopenia. The combination of these signs, symptoms, and lab findings should lead you to suspect compensated cirrhosis. To confirm the diagnosis, obtain an abdominal ultrasound, as well as ultrasound with elastography. Additionally, you can obtain a liver biopsy, which is the gold standard for diagnosis. Abdominal ultrasound will reveal a small nodular liver, as well as the absence of ascites, while ultrasound with elastography may show increased liver stiffness. Lastly, liver biopsy is not always done, but it may help confirm the diagnosis by showing regenerative nodules and fibrotic tissue.

Okay, now that you’ve confirmed the diagnosis of compensated cirrhosis, let's turn our attention to management. First, you’ll want to treat the underlying cause of cirrhosis. For example, if your patient has viral hepatitis, start them on antiviral medications; or if they use alcohol, encourage abstinence and get them specialty treatment for alcohol use disorder. Also be sure to encourage additional lifestyle modifications, like weight loss for those with steatohepatitis, as well as avoiding heavily processed foods, and limiting hepatotoxic and nephrotoxic medications, like NSAIDs.

Offer vaccination for Hepatitis A and B, and screen for hepatocellular carcinoma every 6 months by obtaining an ultrasound with or without measuring blood concentrations of alpha-fetoprotein. You should also screen for esophageal varices at the time of diagnosis and every 2 to 3 years thereafter. In addition, calculate your patient’s MELD-Na score and Child-Pugh scores. Lastly consult the surgical team for transfer to a transplant center as your patient could be a candidate for liver transplant. Transplant is the only definitive treatment for cirrhosis.

Sources

  1. "AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis" Hepatology (2023)
  2. "AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis" Hepatology (2022)
  3. "Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases" Hepatology (2021)
  4. "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation" Am Fam Physician (2006)
  5. "Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis" J Coll Physicians Surg Pak (2010)